N-{3-methyl-5-[2-(pyridin-4-ylamino)-ethoxy]-phenyl}-benzenesulfonamide (I48) Summary

Clusters summary
Clustering method gromos
Clustering metric RSMdi
Initial clustering cutoff (nm) 0.05
Final clustering cutoff (nm) 0.13
Number of clusters 25
Number of clusters representing 95% 9
Cluster Population
Clusters Convergence
ΔG WITH RESPECT TO BIOACTIVE CONFORMATION
ΔGdist (kcal/mol) 1.1451
ΔGstrain (kcal/mol) 0.1375
Conformations Table
ClNum ClPop ΔG Cl-Cl RMSd Exp
1 1824 0 1.698
2 1597 0.0787 2.4193
3 1446 0.1375 1.4273
4 1230 0.2333 1.5008
5 1183 0.2564 1.9584
6 1104 0.2973 2.8449
7 573 0.6856 1.88
8 553 0.7067 3.0592
9 415 0.8767 1.981
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)